- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04557124
USS Training to Improve Social Function in People With Psychosis
November 7, 2023 updated by: VA Office of Research and Development
Understanding Social Situations (USS): Training to Improve Social Function in People With Psychosis
Psychotic spectrum disorders (PSD) are associated with poor social function.
By doing this study, the investigators hope to learn which of two different types of 2-month long training courses is more effective in improving day-to-day interactions and quality of life.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Participants will be randomly assigned to one of the two training courses.
All participants will be asked to fill out questionnaires, engage in interviews, and complete paper and pencil tasks at the beginning of the study, at the halfway point of the training course (1 month), and end of the training course (2 months), and another 2 months later.
One training focuses on how to make good judgments about what other people may be thinking or feeling in social situations, and why people might act in certain ways in different situations.
The other training focuses on different strategies for handling everyday problems and stressors.
Both trainings are done in one-on-one sessions with a research staff member.
There will be 16-20 training sessions, each about 45-60 minutes long.
The investigators will ask participants to attend 2 training sessions per week, so the total training time should be about 2 months.
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joanna M Fiszdon, PhD
- Phone Number: 2231 (203) 932-5711
- Email: joanna.fiszdon@va.gov
Study Locations
-
-
Connecticut
-
West Haven, Connecticut, United States, 06516-2770
- Recruiting
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT
-
Contact:
- Joanna M Fiszdon, PhD
- Phone Number: 2231 203-932-5711
- Email: joanna.fiszdon@va.gov
-
Principal Investigator:
- Joanna M. Fiszdon, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Veteran with diagnosis of psychotic disorder (e.g. schizophrenia, schizoaffective disorder, delusional disorder, psychosis NOS, etc);
- psychiatrically stable (30 or more days since last hospitalization/change in psychiatric medication)
- fluent in English
- able to provide legal written informed consent
Exclusion Criteria:
- current substance use disorder
- developmental disability
- severe, uncorrected auditory/visual impairment
- diagnosis of medical or neurological illness known to impair brain function including dementia, presence of seizures, history of head trauma with loss of consciousness > 1hr, or clear cognitive sequelae from other illness or injury
- currently enrolled in another treatment study targeting, or expected to impact, functioning.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: USS
social cognitive training
|
social cognitive training
|
Active Comparator: MovingForward
problem solving training
|
problem solving training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Functioning Scale (SFS) Change
Time Frame: pre-training, mid-training (1 month), post-training (2 months), follow-up (4 months)
|
self-report measure of social functioning
|
pre-training, mid-training (1 month), post-training (2 months), follow-up (4 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Skills Performance Assessment (SSPA) Change
Time Frame: pre-training, post-training (2 months), follow-up (4 months)
|
social interaction skill role-play
|
pre-training, post-training (2 months), follow-up (4 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Joanna M. Fiszdon, PhD, VA Connecticut Healthcare System West Haven Campus, West Haven, CT
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2020
Primary Completion (Estimated)
September 30, 2024
Study Completion (Estimated)
September 30, 2025
Study Registration Dates
First Submitted
September 14, 2020
First Submitted That Met QC Criteria
September 18, 2020
First Posted (Actual)
September 21, 2020
Study Record Updates
Last Update Posted (Actual)
November 8, 2023
Last Update Submitted That Met QC Criteria
November 7, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D3354-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
see below
IPD Sharing Time Frame
Data will be available once primary and secondary study aims have been published.
IPD Sharing Access Criteria
Completely de-identified data will be made available to other investigators, with written request and IRB approval, ideally under a data use agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
University of California, San DiegoCenter for Medicinal Cannabis ResearchRecruitingEarly PsychosisUnited States
-
Yale UniversityCompleted
-
University of TorontoUniversity of British Columbia; Centre for Addiction and Mental Health; Queen... and other collaboratorsNot yet recruitingPsychotic Disorders | Schizophrenia | Psychosis | Schizophrenia; Psychosis
-
Northwell HealthNational Institute of Mental Health (NIMH)RecruitingFirst Episode PsychosisUnited States
-
State reference center for psychosocial careUniversity of ValenciaCompleted
Clinical Trials on USS
-
K2M, Inc.WithdrawnAdolescent Idiopathic ScoliosisUnited Kingdom
-
University of VirginiaJuvenile Diabetes Research FoundationCompleted
-
University of VirginiaCompletedType 1 DiabetesUnited States
-
University of VirginiaStanford UniversityCompleted
-
University of VirginiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford... and other collaboratorsCompletedType 1 Diabetes MellitusUnited States
-
Rijnstate HospitalTerminatedCOPD Exacerbation | Enoximone | Phosphodiesterase InhibitorNetherlands
-
University College, LondonUniversity College London HospitalsUnknownLupus Erythematosus, SystemicUnited Kingdom
-
Gilead SciencesAstraZenecaTerminatedEnoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart FailureHeart Failure, CongestiveUnited States